2-Methoxyestradiol-3,17-O,O-bis-sulfamate (STX140) inhibits proliferation and invasion via senescence pathway induction in human BRAFi-resistant melanoma cells
The endogenous estradiol derivative 2-Methoxyestradiol (2-ME) has shown good and wide anticancer activity but suffers from poor oral bioavailability and extensive metabolic conjugation. However, its sulfamoylated derivative, 2-methoxyestradiol-3,17-O,O-bis-sulfamate (STX140), has superior potential...
Main Authors: | Franco, YA, Oliveira de Moraes, Jr., M, Carvalho, LAC, Dohle, W, Oliveira da Silva, R, Noma, IHY, Lima, K, Potter, BVL, Machado-Neto, JA, Maria-Engler, SS |
---|---|
Format: | Journal article |
Language: | English |
Published: |
MDPI
2023
|
Similar Items
-
2-Methoxyestradiol-3,17-<i>O</i>,<i>O</i>-bis-sulfamate (STX140) Inhibits Proliferation and Invasion via Senescence Pathway Induction in Human BRAFi-Resistant Melanoma Cells
by: Ylana Adami Franco, et al.
Published: (2023-07-01) -
2-Methoxyestradiol-3,17-O,O-bis-sulfamate inhibits store-operated Ca2+ entry in T lymphocytes and prevents experimental autoimmune encephalomyelitis
by: Hosang, L, et al.
Published: (2023) -
Novel anti-Acanthamoebic activities of Irosustat and STX140 and their nanoformulations
by: Siddiqui, R, et al.
Published: (2023) -
Novel Anti-Acanthamoebic Activities of Irosustat and STX140 and Their Nanoformulations
by: Ruqaiyyah Siddiqui, et al.
Published: (2023-03-01) -
Cell Fate following Irradiation of MDA-MB-231 and MCF-7 Breast Cancer Cells Pre-Exposed to the Tetrahydroisoquinoline Sulfamate Microtubule Disruptor STX3451
by: Scott D. Hargrave, et al.
Published: (2022-06-01)